We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 531

When You Wish Upon a Puppy CARU Steps In
  • Manatt Phelps & Phillips LLP
  • USA
  • January 17 2019

Just in time for the holidays, the Children's Advertising Review Unit (CARU) cracked down on television ads for the Wish Me Puppy and recommended


NAD Refers BodyArmor Claims to FTC After Review
  • Manatt Phelps & Phillips LLP
  • USA
  • December 6 2018

After BA Sports Nutrition declined to comply with the National Advertising Division's (NAD) recommendations to modify or discontinue certain ad


Body Armor's All-Natural Sports Drink Claims Are Superiority Claims, Says NA
  • Baker & Hostetler LLP
  • USA
  • December 5 2018

Complaints from competitor Gatorade kicked to the FTC Snark The advertisements were clever. The conceit of Body Armor Sports Drink's television ad


HHS Proposes Disclosure of Drug Prices in TV Advertising, But Fight Over Authority On the Horizon
  • Arent Fox LLP
  • USA
  • October 29 2018

The Department of Health and Human Services (HHS) has issued a proposed rule (PR) which would require any television advertisement for a drug or


FDA Warns Against Sales Representative’s “False and Misleading” Oral Statements Regarding Prescription Medicine
  • Drinker Biddle & Reath LLP
  • USA
  • October 25 2018

The U.S. Food and Drug Administration’s Office of Prescription Drug Promotion (OPDP) sent an untitled letter to Eisai Inc. on October 11, 2018, based


Seventh Circuit Not Moooved by False Advertising Appeal
  • Baker & Hostetler LLP
  • USA
  • July 9 2018

Back in 2017, Arla Foods launched a series of 30-second TV spots as part of a $30 million campaign to expand


Coming soon from FDA? Streamlined safety information in prescription drug television ads
  • DLA Piper
  • USA
  • September 7 2017

Most people are by now familiar with prescription drug TV ads that provide lengthy (and often confusing) laundry-list descriptions of


ASA Adjudications Snapshot - March and April 2017
  • CMS Cameron McKenna Nabarro Olswang LLP
  • United Kingdom
  • May 26 2017

This summary provides a selection of March and April’s most interesting ASA adjudications and highlights the key issues considered in those rulings


NAD Consumer Protection in Retail: Weekly Roundup
  • Hunton Andrews Kurth LLP
  • USA
  • August 4 2016

The National Advertising Division (“NAD”) was busy this past week. The organization recommended that several companies modify or discontinue claims


Biosimilar applicants must provide notice of commercial marketing
  • Fanelli Haag
  • USA
  • July 19 2016

In a recent case involving Apotex’s proposed biosimilar product to Amgen’s Neulasta (pegfilgrastim). Amgen sought a preliminary injunction to